Smith+Nephew announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure ...
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial ...
On Wednesday, the FDA issued a new draft guidance proposing to reduce the need for sponsors to conduct a comparative efficacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback